Neos Therapeutics to Host First Quarter 2018 Financial Results Conference Call on May 9, 2018
May 02, 2018 07:30 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, May 02, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results
March 15, 2018 07:00 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 15, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Host Fourth Quarter and Year-End 2017 Financial Results Conference Call on March 15, 2017
March 08, 2018 07:30 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the Cowen & Co. Annual Health Care Conference
March 05, 2018 08:00 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 05, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Launches Adzenys ER™ (amphetamine) Extended-Release Oral Suspension in U.S. for the Treatment of ADHD in Patients 6 Years and Older
February 26, 2018 08:00 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Feb. 26, 2018 (GLOBE NEWSWIRE) --
Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing...
Neos Therapeutics to Present Three Posters at the Upcoming American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting
January 10, 2018 08:00 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Neos Therapeutics to Participate in Two December Conferences
November 28, 2017 08:00 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Neos Therapeutics Reports Third Quarter 2017 Financial Results
November 08, 2017 07:00 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the Stifel 2017 Healthcare Conference
November 07, 2017 08:00 ET
|
Neos Therapeutics, Inc.
DALLAS/FORT WORTH, Texas, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Neos Therapeutics to Host Third Quarter 2017 Financial Results Conference Call on November 8, 2017
November 02, 2017 08:00 ET
|
Neos Therapeutics, Inc.
DALLAS/FORT WORTH, Texas, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...